primari
caus
acut
chest
syndrom
ac
report
pulmonari
fat
embol
infarct
singleor
mixedpathogen
infect
studi
nation
acut
chest
syndrom
studi
group
differ
infecti
pathogen
identifi
episod
ac
patient
sickl
cell
diseas
chlamydophila
pneumonia
frequent
follow
mycoplasma
pneumonia
respiratori
syncyti
viru
rsv
coagulaseposit
stapyhylococcu
aureu
streptococcu
pneumonia
mycoplasma
homini
parvoviru
c
pneumonia
pneumonia
influenza
well
recogn
pathogen
associ
ac
studi
howev
studi
use
molecular
method
detect
studi
infect
human
rhinoviru
hrv
human
coronaviru
hcov
human
bocaviru
hbov
human
enteroviru
hev
human
metapneumoviru
hmpv
hrv
hcov
infect
common
children
associ
hospit
acut
respiratori
ill
howev
littl
known
clinic
impact
infect
emerg
respiratori
virus
children
sickl
cell
diseas
hypothes
hrv
common
respiratori
viru
detect
popul
coinfect
multipl
virus
predispos
patient
ac
evalu
prospect
analyz
respiratori
sampl
children
sickl
cell
diseas
diagnos
acut
respiratori
ill
hrv
hcov
hbov
hev
human
adenoviru
hadv
hmpv
parainfluenza
viru
piv
rsv
influenza
c
pneumonia
pneumonia
bordetella
pertussi
use
multiplexedpolymeras
chain
reaction
pcr
children
year
sickl
cell
diseas
diagnos
acut
respiratori
ill
inpati
unit
outpati
clinic
st
jude
children
research
hospit
sjcrh
elig
enrol
prospect
conduct
cohort
studi
clinic
characterist
patient
without
respiratori
viru
clinic
characterist
distribut
respiratori
virus
patient
without
ac
evalu
durat
studi
one
year
octob
septemb
studi
approv
sjcrh
institut
review
board
waiver
consent
obtain
nasopharyng
wash
sampl
collect
order
treat
physician
base
presenc
symptom
acut
respiratori
ill
time
initi
present
nasopharyng
wash
obtain
use
presalin
fill
syring
aspir
kit
npak
annandal
mn
minimum
ml
aspir
collect
transport
immedi
sjcrh
microbiolog
background
human
rhinoviru
hrv
human
coronaviru
hcov
human
bocaviru
hbov
human
metapneumoviru
hmpv
infect
children
sickl
cell
diseas
well
studi
procedur
nasopharyng
wash
specimen
prospect
collect
children
sickl
cell
diseas
acut
respiratori
ill
period
sampl
test
multiplexedpcr
use
autom
system
nine
respiratori
virus
chlamydophila
pneumonia
mycoplasma
pneumonia
bordetella
pertussi
clinic
characterist
distribut
respiratori
virus
patient
without
acut
chest
syndrom
ac
evalu
result
respiratori
viru
detect
patient
nine
patient
ac
respiratori
viru
detect
demograph
characterist
patient
without
ac
similar
hrv
common
viru
detect
patient
logist
regress
show
associ
ac
detect
hrv
hcov
hbov
hmpv
respiratori
pathogen
coinfect
least
one
addit
respiratori
viru
seen
infect
patient
significantli
higher
patient
ac
p
coinfect
two
respiratori
virus
seen
seven
patient
patient
without
ac
bacteri
pathogen
detect
conclus
hrv
common
viru
detect
children
sickl
cell
diseas
acut
respiratori
ill
associ
increas
morbid
larger
prospect
studi
asymptomat
control
need
studi
associ
emerg
respiratori
virus
ac
children
sickl
cell
diseas
pediatr
blood
cancer
laboratori
ice
diagnost
studi
perform
respiratori
panel
includ
test
piv
rsv
influenza
influenza
b
hadv
hmpv
result
avail
physician
report
aliquot
sampl
remain
complet
clinic
diagnost
test
aliquot
test
multiplexedpcr
previous
describ
remov
patient
identifi
physician
blind
result
test
aliquot
data
research
studi
use
clinic
care
test
aliquot
perform
use
autom
broadli
multiplex
pcr
system
filmarray
biofir
diagnost
inc
salt
lake
citi
ut
integr
specimen
process
nest
multiplexedpcr
system
enabl
simultan
detect
hrv
hbov
hev
piv
rsv
influenza
influenza
influenza
influenza
influenza
b
hadv
hmpv
pneumonia
c
pneumonia
b
pertussi
acut
respiratori
ill
defin
presenc
two
follow
symptom
fever
rhinorrhea
cough
nasal
congest
otiti
media
pharyng
patient
chest
pain
temperatur
tachypnea
wheez
cough
new
pulmonari
infiltr
chest
radiographi
involv
least
one
complet
lung
segment
consist
presenc
alveolar
consolid
exclud
atelectasi
diagnos
ac
patient
without
ac
lung
find
examin
day
infect
onset
defin
day
first
posit
sampl
collect
patient
consid
infect
respiratori
viru
detect
multiplexedpcr
clinic
data
abstract
prospect
collect
databas
includ
patient
demograph
past
medic
histori
ever
suffer
vasoocclus
crise
ac
asthma
use
hydroxyurea
result
recent
hemoglobin
electrophoresi
presenc
absenc
ac
radiolog
find
copathogen
need
oxygen
therapi
treatment
receiv
hemoglobin
white
blood
cell
count
present
durat
inpati
stay
admiss
intens
care
unit
acut
respiratori
ill
descript
statist
patient
without
respiratori
viru
patient
without
ac
provid
preval
respiratori
virus
patient
without
ac
includ
fisher
exact
test
mannwhitney
test
use
compar
patient
without
respiratori
viru
without
ac
categor
continu
variabl
respect
fisher
exact
test
use
studi
associ
individu
virus
coinfect
ac
exact
mcnemar
test
use
comparison
frequenc
hrv
eight
virus
first
sampl
test
posit
viru
use
purpos
first
episod
acut
respiratori
ill
use
analysi
whether
viru
isol
univari
logist
regress
analysi
perform
determin
patient
acut
respiratori
ill
elig
enrol
studi
respiratori
viru
detect
patient
demograph
clinic
characterist
patient
detail
tabl
patient
ac
respiratori
viru
detect
latter
patient
ac
treat
inpati
longer
length
hospit
p
higher
white
blood
cell
count
p
compar
patient
without
ac
present
symptom
sign
patient
ac
includ
cough
fever
tachypnea
chest
pain
short
breath
patient
two
patient
oxygen
requir
nasal
cannula
day
patient
requir
admiss
intens
care
unit
present
symptom
patient
respiratori
viru
without
ac
includ
cough
nasal
congest
fever
pharyng
patient
respect
patient
clinic
sign
radiolog
evid
lower
respiratori
tract
involv
hrv
common
respiratori
viru
detect
comparison
hadv
p
hcov
p
influenza
p
piv
p
hbov
p
hev
p
hmpv
p
rsv
p
detect
patient
ac
patient
without
ac
coinfect
least
one
addit
respiratori
viru
seen
infect
patient
significantli
higher
patient
ac
p
tabl
ii
pneumonia
c
pneumonia
b
pertussi
identifi
cohort
patient
bacteri
pathogen
identifi
blood
cultur
obtain
febril
patient
coinfect
two
respiratori
virus
seen
seven
patient
patient
without
ac
three
patient
coinfect
three
virus
two
four
virus
two
five
virus
manag
outpati
except
patient
rsv
hrv
hcov
infect
present
croup
treat
racem
epinephrin
dexamethason
discharg
day
univari
logist
regress
show
associ
patient
ac
age
p
odd
ratio
ci
male
gender
p
odd
ratio
ci
hrv
p
odd
ratio
ci
hcov
p
odd
ratio
ci
hbov
p
odd
ratio
ci
hev
p
odd
ratio
ci
piv
p
odd
ratio
ci
rsv
p
influenza
p
hadv
p
hmpv
p
patient
ac
rsv
hadv
influenza
viru
detect
one
patient
ac
detect
hmpv
patient
respiratori
viru
detect
except
one
patient
ac
upper
respiratori
tract
infect
patient
upper
respiratori
tract
infect
patient
ac
octob
march
patient
upper
respiratori
tract
infect
patient
ac
april
septemb
respect
differ
distribut
patient
upper
respiratori
tract
infect
signific
p
respiratori
virus
detect
patient
octob
march
patient
april
septemb
fig
patient
hrv
hbov
hcov
infect
detect
octob
march
compar
patient
respect
april
septemb
differ
statist
signific
hrv
p
hbov
p
hcov
p
influenza
rsv
infect
detect
octob
march
piv
infect
detect
yearround
acut
respiratori
infect
major
caus
morbid
patient
sickl
cell
diseas
contribut
etiolog
ac
past
year
newli
discov
virus
includ
coronavirus
human
metapneumoviru
bocaviru
enteroviru
rhinoviru
implic
causat
lower
respiratori
tract
diseas
immunecompet
immunecompromis
children
howev
role
patient
sickl
cell
diseas
defin
knowledg
first
prospect
studi
hrv
hcov
hbov
hev
hmpv
respiratori
infect
popul
hrv
member
famili
picornavirida
well
recogn
caus
upper
respiratori
tract
ill
recent
sever
studi
report
hrv
may
associ
sever
lower
respiratori
tract
ill
hospit
otherwis
healthi
children
although
common
respiratori
viru
detect
popul
hrv
associ
increas
rate
hospit
morbid
ac
coronavirus
caus
upper
respiratori
ill
lower
respiratori
tract
diseas
infant
immunocompromis
patient
two
patient
studi
hcov
detect
sole
pathogen
one
ac
preval
hcov
infect
may
also
significantli
higher
immunecompet
children
compar
asymptomat
control
hbov
associ
coinfect
studi
sole
pathogen
similar
rate
detect
hbov
shown
immunecompet
patient
pneumonia
coinfect
respiratori
virus
compar
control
role
viru
respiratori
pathogen
present
remain
unproven
human
enteroviru
associ
coinfect
studi
mostli
patient
upper
respiratori
tract
infect
howev
human
enteroviru
report
case
seri
caus
sever
pneumonia
recipi
stem
cell
transplant
respiratori
infect
hmpv
shown
associ
substanti
burden
hospit
outpati
visit
young
mostli
previous
healthi
children
none
patient
influenza
infect
develop
ac
perhap
due
earli
initi
therapi
oseltamivir
infect
season
strain
infect
pandem
strain
shown
associ
ac
requir
mechan
ventil
contrast
infect
season
influenza
strain
studi
shown
posit
associ
viral
codetect
wors
clinic
outcom
infant
lower
respiratori
tract
infect
rsv
hrv
codetect
longer
durat
hospit
stay
need
supplement
oxygen
compar
rsv
alon
infant
bronchiol
viral
coinfect
hmpv
rsv
like
requir
intens
care
admiss
mechan
ventil
howev
coinfect
hmpv
respiratori
virus
result
increas
diseas
sever
anoth
studi
multivir
infect
associ
ac
studi
although
sampl
size
small
major
limit
studi
lack
asymptomat
control
patient
sickl
cell
diseas
healthi
asymptomat
immunecompet
patient
shed
hrv
hcov
known
true
patient
sickl
cell
diseas
cohort
size
number
patient
ac
small
limit
conclus
made
demograph
characterist
durat
shed
determin
larger
prospect
studi
asymptomat
control
patient
consid
studi
associ
emerg
respiratori
virus
ac
sinc
bronchoalveolar
lavag
perform
copathogen
may
either
detect
overrepres
hydroxyurea
shown
reduc
frequenc
ac
episod
seen
studi
perhap
due
small
sampl
size
studi
advantag
prospect
design
use
multiplex
molecular
diagnost
detect
newli
describ
emerg
respiratori
virus
uniqu
popul
examin
associ
found
ac
pediatr
blood
cancer
doi
hrv
hcov
hbov
hev
infect
popul
virus
detect
predominantli
respiratori
season
rather
year
around
multivir
infect
also
increasingli
recogn
use
newer
diagnost
method
shown
associ
ac
pcrbase
assay
emerg
respiratori
virus
recent
becom
commerci
avail
studi
need
determin
clinic
util
test
studi
effect
virus
longterm
pulmonari
function
ac
healthcar
util
patient
without
respiratori
viru
detect
pleconaril
shown
significantli
improv
recoveri
hrv
infect
accur
diagnosi
infect
may
henc
implic
infect
control
treatment
